YOUL vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

YOUL

45.2
AI Score
VS
YOUL Wins

UTI

43.7
AI Score

Investment Advisor Scores

YOUL

45score
Recommendation
HOLD

UTI

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric YOUL UTI Winner
Revenue 265.16M 835.62M UTI
Net Income 6.16M 63.02M UTI
Net Margin 2.3% 7.5% UTI
Operating Income 967,000 83.47M UTI
ROE 5.9% 19.2% UTI
ROA 3.5% 7.6% UTI
Total Assets 177.73M 826.14M UTI
Cash 20.62M 127.36M UTI
Current Ratio 2.02 1.07 YOUL
Free Cash Flow 1.71M 55.35M UTI

Relative Price Performance (Last 90 Days)

YOUL 1M: -40.6% · 3M: -53.6% UTI 1M: -3.1% · 3M: -44.2%

Current Technical Phase

YOUL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 27

RSI (14): 26.5 · Price: $0.28

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $20.81

Fundamentals Snapshot

Metric YOUL UTI
Market Cap — —
Forward P/E 2.6 28.3
Trailing P/E 4.9 34.3
Revenue (TTM) — —
Revenue Growth 1.1% 0.1%
Gross Margin 0.1% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.06 0.60
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, YOUL is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.